Vital Therapies (NASDAQ:VTL)

Cell-based therapy targeting the treatment of acute liver failure.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Vital Therapies (NASDAQ:VTL) plus 5980 other startups.

Learn More About Vital Therapies (NASDAQ:VTL)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More